Outset Medical secures $125m financing for Tablo hemodialysis system
The series E equity financing round was headed by investment advisory firm D1 Capital Partners
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Feb 20
The series E equity financing round was headed by investment advisory firm D1 Capital Partners
05 Feb 20
Goal to enroll up to 60 patients in twelve month study accrual period
05 Feb 20
The agreement will enable Baxter to expand its Acute Therapies portfolio to address unmet needs and will provide…
US tech company Medidata has 20 years of experience in using software to improve the effectiveness of clinical…
04 Feb 20
Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management…
03 Feb 20
Under the first phase of the partnership, Biofourmis' artificial intelligence(AI)-powered RhythmAnalytics will be integrated with ImagineMIC's remote management…
31 Jan 20
New insights come as Profusa receives CE Mark for its latest generation device, the Wireless Lumee Oxygen Platform
31 Jan 20
The EyeOn platform delivers premium design and performance for the AAC market
29 Jan 20
BioSticker device is said to be the first single-use medical device that enables 30 days of continuous vital…
29 Jan 20
The CE mark approval allows Profusa to commercialise the oxygen monitoring device for physician offices, hospitals, ambulatory care…